logo

Judith Currier, MD

Judith Currier, MD

Infectious Disease Los Angeles, CA

Professor of Medicine, UCLA-David Geffen School of Medicine

Office Address

Office Map
  • 200 Medical Plaza
    #214,365,530,420,120
    Los Angeles, CA 90095
    Phone: (310) 557-2273

Dr. Currier's Clinical Specialties & Interests

  • Infectious Disease: HIV/AIDS Medicine

Dr. Currier's Education & Medical Training

  • Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical CenterFellowship, Infectious Disease
  • Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical CenterResidency, Internal Medicine
  • Dartmouth MedGeisel School of Medicine at DartmouthMedical School

Dr. Currier's Certifications & Licensure

  • CA State Medical LicenseCA State Medical License1993 - 2014
  • GA State Medical LicenseGA State Medical LicenseActive through 2013
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineInfectious Disease

Dr. Currier's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Currier's Clinical Trials

Dr. Currier's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Optimizing Antiretroviral Therapy In HIV
    Optimizing Antiretroviral Therapy In HIVNational Institute Of Allergy And Infectious Diseases
    2009 - 2012
  • Prospective Evaluation Of Antiviral Therapy And Cardiac Health
    Prospective Evaluation Of Antiviral Therapy And Cardiac HealthNational Heart, Lung, And Blood Institute
    2008 - 2011
  • Clinical Research Facilitation Core
    Clinical Research Facilitation CoreNational Institute Of Allergy And Infectious Diseases
    2008 - 2012
  • UCLA AIDS Prevention And Treatment Clinical Trials Unit
    UCLA AIDS Prevention And Treatment Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    2007 - 2012
  • A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)
    A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)National Center For Research Resources
    2007 - 2008
  • Sex Differences In Pharmacokinetics Of Lopinavir/Ritonavir Among HIV-1 Infect
    Sex Differences In Pharmacokinetics Of Lopinavir/Ritonavir Among HIV-1 InfectNational Center For Research Resources
    2007 - 2008
  • A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of Uridine
    A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of UridineNational Center For Research Resources
    2007 - 2009
  • A Phase IV, Prospective, Randomized, Open-Label Evaluation Of The Efficacy Of
    A Phase IV, Prospective, Randomized, Open-Label Evaluation Of The Efficacy OfNational Center For Research Resources
    2006 - 2010
  • Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin
    Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients ReceivinNational Center For Research Resources
    2006 - 2008
  • Phase II, Randomized, Double-Blind Study Of The Safety And Efficacy Of SCH 41
    Phase II, Randomized, Double-Blind Study Of The Safety And Efficacy Of SCH 41National Center For Research Resources
    2006 - 2010
  • Fat Redistribution And Metabolic Change In HIV Infection: Protocol 2 (Fram 2)
    Fat Redistribution And Metabolic Change In HIV Infection: Protocol 2 (Fram 2)National Center For Research Resources
    2006 - 2007
  • Stavudine Drugs &Risk Metabolic Toxicity: PATS Recv Antiretroviral Therapy:Aids
    Stavudine Drugs &Risk Metabolic Toxicity: PATS Recv Antiretroviral Therapy:AidsNational Center For Research Resources
    2005 - 2005
  • A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Of Once-Weekly
    A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Of Once-WeeklyNational Center For Research Resources
    2005 - 2005
  • A Randomized, Double-Blind, Placebo-Controlled Study Of Metformin And Rosigli
    A Randomized, Double-Blind, Placebo-Controlled Study Of Metformin And RosigliNational Center For Research Resources
    2005 - 2005
  • A Study Investigating Plasma Levels Of D-Chiro-Inositol In Patients With HIV
    A Study Investigating Plasma Levels Of D-Chiro-Inositol In Patients With HIVNational Center For Research Resources
    2005 - 2005
  • Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr
    Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (AllrNational Center For Research Resources
    2005 - 2006
  • A Prospective Observational Study Of Virologic And Immunologic Changes In HIV
    A Prospective Observational Study Of Virologic And Immunologic Changes In HIVNational Center For Research Resources
    2005 - 2006
  • Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr...
    Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr...National Center For Research Resources
    2004 - 2004
  • Study Investigating Plasma Levels Of D-Chiro-Inositol
    Study Investigating Plasma Levels Of D-Chiro-InositolNational Center For Research Resources
    2004 - 2004
  • AIDS Clinical Trials Unit
    AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    2004 - 2006
  • Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin...
    Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin...National Center For Research Resources
    2004 - 2004
  • Phase II, Randomized, Double-Blind, Placebo-Controlled
    Phase II, Randomized, Double-Blind, Placebo-ControlledNational Center For Research Resources
    2004 - 2004
  • Randomized, Double-Blind, Placebo-Controlled Study Of
    Randomized, Double-Blind, Placebo-Controlled Study OfNational Center For Research Resources
    2004 - 2004
  • Pilot Study Of The Safety, Efficacy, And Tolerability
    Pilot Study Of The Safety, Efficacy, And TolerabilityNational Center For Research Resources
    2004 - 2004
  • Metabolic Complication Of HIV Infection
    Metabolic Complication Of HIV InfectionNational Institute Of Allergy And Infectious Diseases
    2003 - 2007
  • STD Faculty Expansion Program
    STD Faculty Expansion ProgramNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention
    2003 - 2006
  • Actg365--Steady State PK Interaction Study Of Indinavir &Rifabutin
    Actg365--Steady State PK Interaction Study Of Indinavir &RifabutinNational Center For Research Resources
    1999 - 2002
  • 24 Week Study Of Indinavir Sulfate 800 MG Q8h Versus 1200 MG Q12h
    24 Week Study Of Indinavir Sulfate 800 MG Q8h Versus 1200 MG Q12hNational Center For Research Resources
    1999 - 2002
  • Viracept (BID) And Sanquinavir (BID) Compared With Tid Dosing In HIV
    Viracept (BID) And Sanquinavir (BID) Compared With Tid Dosing In HIVNational Center For Research Resources
    1999 - 2002
  • Phase II, Randomized Trial Of Amprenavir As PART Of Dual Protease Inhibitor
    Phase II, Randomized Trial Of Amprenavir As PART Of Dual Protease InhibitorNational Center For Research Resources
    1999 - 2001
  • Phase I/II Trial Of Nandrolone Decanoate In Women W/ HIV Associated Weight Loss
    Phase I/II Trial Of Nandrolone Decanoate In Women W/ HIV Associated Weight LossNational Center For Research Resources
    1998 - 2002
  • Phase II, Randomized Study Of The Safety And Efficacy Of Viracept
    Phase II, Randomized Study Of The Safety And Efficacy Of ViraceptNational Center For Research Resources
    1998 - 1999

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS California CaliforniaCare HMO
  • BCBS California PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • Pacificare HMO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Judith Currier, Dr. Judith Currier, MD, Dr. J Currier, Dr. Judith Silverstein Currier

31 Colleague Invites!
Is this you? If so, register to see 31 messages.

Physicians, view Dr. Currier's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV